Advertisement
UK markets close in 7 hours 53 minutes
  • FTSE 100

    7,843.52
    -33.53 (-0.43%)
     
  • FTSE 250

    19,302.46
    -148.21 (-0.76%)
     
  • AIM

    741.68
    -3.61 (-0.48%)
     
  • GBP/EUR

    1.1680
    -0.0003 (-0.02%)
     
  • GBP/USD

    1.2442
    +0.0003 (+0.02%)
     
  • Bitcoin GBP

    51,908.91
    +2,762.91 (+5.62%)
     
  • CMC Crypto 200

    1,325.08
    +12.45 (+0.95%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    83.70
    +0.97 (+1.17%)
     
  • GOLD FUTURES

    2,401.70
    +3.70 (+0.15%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,250.99
    -134.88 (-0.82%)
     
  • DAX

    17,659.99
    -177.41 (-0.99%)
     
  • CAC 40

    7,969.10
    -54.16 (-0.67%)
     

Spain to make coronavirus vaccination optional, sources say

FILE PHOTO: Outbreak of the coronavirus disease (COVID-19) in Alpedrete

MADRID (Reuters) - Spain is unlikely to make vaccination against the coronavirus compulsory, at least initially, health ministry sources said on Monday.

Under Spanish law, vaccination is voluntary, although in some cases, such as an epidemic, the government could make it compulsory.

"There are instruments to make it so. But it is not the plan at the moment," one source said, while another said all vaccination was likely to remain optional.

Prime Minister Pedro Sanchez said on Sunday that Spain would begin a coronavirus vaccination programme in January, covering a substantial part of the population within six months.

ADVERTISEMENT

The sources said, however, there was still not enough information about the Phase 3 trials of the most promising vaccines to say which Spain would buy, how it would transport and store them or who would be vaccinated first.

They said that when all the data is available and vaccines authorised for use in the European Union, Spain can quickly vaccinate much of its population thanks to its "vast vaccination experience" via a network of public healthcare centres.

AstraZeneca said on Monday its vaccine could be as much as 90% effective. It is cheaper to make, easier to distribute and faster to scale-up than rivals from Pfizer Inc or Moderna.

(Reporting by Emma Pinedo and Andrei Khalip; Editing by Giles Elgood)